Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical photodynamic therapy with nanoemulsion 5-aminolevulinic acid for actinic keratosis
2006-000314-20Phase 2Terminated
- Sponsor
- Biofrontera
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in actinic keratosis (AK) comparing 5-aminolevulinic acid nanoemulsion + photodynamic therapy with Placebo nanoemulsion + photodynamic therapy (2 arms). Primary endpoint: Total clearance rate of actinic keratosis lesions. Started May 2006; status: terminated.
02
Drugs
5-aminolevulinic acid
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2006-000314-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000314-20.